Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
XenoGesis
XenoGesis
Activities:
Research & Development
X
LinkedIn
Trending Articles
AI-driven manufacturing: revolutionising chemical additive optimisation for industrial processes
The integration of artificial intelligence (AI) and machine learning (ML) into manufacturing processes represents a significant leap forward for the industry, reports Josh...
The IMA Group at CPHI Milan: welcoming you to Booth 18A1
Discover the all-in-one supplier for the pharmaceutical, personal care, homecare and toiletry Industries
Clariant introduces new high-performing excipients at the CPHI Milan 2024 trade show
Clariant is excited to present the company’s latest portfolio of products for the healthcare industry at the upcoming CPHI trade show in Milan
SRI International awarded US$19.8m National Cancer Institute contract for PREVENT Cancer programme
Will conduct preclinical studies to assess the efficacy of specific compounds or vaccines for preventing invasive-cancer development
Lonza nominates David Meline as independent board member
David Meline brings extensive governance, financial and industry experience to Lonza’s Board of Directors
Upcoming event
ISCC
15-18 October 2024 | Conference | Milan, Italy
See all
Related Content
Drug Delivery
Quay Pharma partners with XenoGesis on drug development
The partnership aims to accelerate the drug development process for both companies’ clients
Research & Development
Contract research organisation XenoGesis expands services
Nottingham, UK-based firm adds CYP induction and gene expression assay services to portfolio
Research & Development
XenoGesis aims to expand into US market
Appoints Sabrina Mogle as a business development specialist to spearhead growth in the region
Research & Development
XenoGesis strengthens DMPK team with appointment of Peter White
He specialises in mass spectrometry and bioanalysis
Research & Development
XenoGesis invests in new cutting-edge technology
Will allow the DMPK and bioanalysis specialist to increase capacity and add new capabilities
Research & Development
XenoGesis appoints Director of External Projects
Graham Trevitt joins the Nottingham, UK-based contract research organisation
Research & Development
UK companies Molecular Profiles and XenoGesis forge partnership
Nottingham-based companies will support drug developers during pre-clinical and formulation stages
Subscribe now